Picture of Compugen logo

CGEN Compugen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Compugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-34.2-33.7-18.8-14.235.3
Depreciation
Non-Cash Items4.234.653.11.31.16
Unusual Items
Other Non-Cash Items
Changes in Working Capital6.82-5.55-20.762-5.35
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-22.7-34.1-35.949.631.6
Capital Expenditures-0.292-0.487-0.172-0.118-0.306
Purchase of Fixed Assets
Other Investing Cash Flow Items6.9137.535.7-46.130.3
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities6.6237.135.5-46.330
Financing Cash Flow Items-0.004
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities16.80.3533.080.55410.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.7042.912.833.9772.4